http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107501405-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 2017-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107501405-B |
| titleOfInvention | An autophagy-inhibiting polypeptide |
| abstract | The invention relates to an autophagy-inhibiting polypeptide whose amino acid sequence is LPDISLKDLQFLQSFCPSEVQ. The autophagy-inhibiting polypeptide can be prepared by artificial synthesis or host cell expression. The polypeptides can be used to prepare drugs for treating tumors. The autophagy-inhibiting polypeptide of the present invention has only 21 amino acids, and it is very convenient and easy to synthesize the polypeptide artificially or express it in a host cell, which is beneficial to large-scale popularization and utilization; It will not cause immune exclusion in animal experiments, and is less toxic to cells and more specific; the inhibitory polypeptide can be stably expressed by introducing the gene fragment encoding the polypeptide into cells by lentivirus or transfection. Conducive to cell-level and animal-level studies. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022186690-A1 |
| priorityDate | 2017-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.